Concourse Financial Group Securities’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-75
Closed -$100 567
2024
Q4
$100 Hold
75
﹤0.01% 2209
2024
Q3
$255 Hold
75
﹤0.01% 2179
2024
Q2
$350 Hold
75
﹤0.01% 2226
2024
Q1
$556 Hold
75
﹤0.01% 2202
2023
Q4
$759 Hold
75
﹤0.01% 2145
2023
Q3
$585 Sell
75
-965
-93% -$8.28K ﹤0.01% 2161
2023
Q2
$8.56K Buy
1,040
+800
+333% +$6.97K ﹤0.01% 1696
2023
Q1
$1.74K Sell
240
-400
-63% -$3.56K ﹤0.01% 2081
2022
Q4
$5.68K Hold
640
﹤0.01% 1816
2022
Q3
$8K Hold
640
﹤0.01% 1533
2022
Q2
$8K Buy
640
+200
+45% +$2.68K ﹤0.01% 1723
2022
Q1
$8K Sell
440
-348
-44% -$6.47K ﹤0.01% 1744
2021
Q4
$21K Sell
788
-637
-45% -$21.9K ﹤0.01% 1611
2021
Q3
$59K Sell
1,425
-107
-7% -$5.86K ﹤0.01% 1240
2021
Q2
$87K Sell
1,532
-1,108
-42% -$40.9K 0.01% 1049
2021
Q1
$111K Buy
2,640
+1,881
+248% +$107K 0.01% 888
2020
Q4
$53K Buy
759
+484
+176% +$19.9K ﹤0.01% 1132
2020
Q3
$8K Hold
275
﹤0.01% 1638
2020
Q2
$8K Hold
275
﹤0.01% 1542
2020
Q1
$5K Hold
275
﹤0.01% 1646
2019
Q4
$8K Buy
275
+75
+38% +$1.87K ﹤0.01% 1491
2019
Q3
$5K Hold
200
﹤0.01% 1306
2019
Q2
$5K Hold
200
﹤0.01% 1719
2019
Q1
$4K Hold
200
﹤0.01% 1797
2018
Q4
$4K Buy
200
+100
+100% +$2.72K ﹤0.01% 1714
2018
Q3
$3K Buy
+100
New +$3.23K ﹤0.01% 1500

Other funds holding EDIT

Concourse Financial Group Securities's EDIT Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 75 shares — an estimated $100 sold.

Concourse Financial Group Securities first reported a position in EDIT in Q3 2018 and held it in 26 quarters. The position peaked at $111K in Q1 2021. 195 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 75 Editas Medicine shares in Q1 2025, an estimated $100.
  • Concourse Financial Group Securities first reported a position in Editas Medicine in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Editas Medicine position peaked at $111K in Q1 2021.
  • 195 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.